Humana Inc. (NYSE:HUM) Shares Purchased by Mandatum Life Insurance Co Ltd

Mandatum Life Insurance Co Ltd raised its holdings in Humana Inc. (NYSE:HUM) by 115.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,000 shares of the insurance provider’s stock after buying an additional 7,500 shares during the quarter. Humana makes up approximately 1.4% of Mandatum Life Insurance Co Ltd’s holdings, making the stock its 19th largest holding. Mandatum Life Insurance Co Ltd’s holdings in Humana were worth $4,434,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Park Avenue Securities LLC grew its holdings in shares of Humana by 6.6% during the 1st quarter. Park Avenue Securities LLC now owns 4,125 shares of the insurance provider’s stock worth $1,430,000 after purchasing an additional 256 shares during the period. Global Assets Advisory LLC purchased a new position in Humana in the 1st quarter worth approximately $5,240,000. Harbor Investment Advisory LLC boosted its holdings in Humana by 4,705.9% in the 1st quarter. Harbor Investment Advisory LLC now owns 817 shares of the insurance provider’s stock worth $283,000 after acquiring an additional 800 shares during the period. Gateway Investment Advisers LLC boosted its holdings in Humana by 124.6% in the 1st quarter. Gateway Investment Advisers LLC now owns 2,201 shares of the insurance provider’s stock worth $763,000 after acquiring an additional 1,221 shares during the period. Finally, Wallace Advisory Group LLC boosted its holdings in Humana by 14.3% in the 1st quarter. Wallace Advisory Group LLC now owns 681 shares of the insurance provider’s stock worth $236,000 after acquiring an additional 85 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on HUM. Truist Financial decreased their price target on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. JPMorgan Chase & Co. upped their target price on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Oppenheimer cut their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Morgan Stanley assumed coverage on Humana in a research report on Monday, June 24th. They set an “equal weight” rating and a $374.00 price target on the stock. Finally, Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and dropped their price target for the company from $519.00 to $253.00 in a research report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $315.33.

Humana Price Performance

HUM stock traded down $4.60 during trading hours on Monday, hitting $262.54. 2,150,224 shares of the stock traded hands, compared to its average volume of 1,848,212. The stock has a 50-day simple moving average of $315.89 and a 200 day simple moving average of $338.56. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company has a market cap of $31.64 billion, a P/E ratio of 16.63, a P/E/G ratio of 1.91 and a beta of 0.50. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter last year, the business posted $8.94 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. Equities analysts forecast that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.35%. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.